We are pleased to announce xFOREST Therapeutics Co., Ltd. is established. Shunichi KASHIDA (left) will become President and CEO and Kaoru Richard KOMATSU (right) will become Chairman of the board and CTO.
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.